154
Participants
Start Date
December 15, 2017
Primary Completion Date
January 10, 2019
Study Completion Date
November 9, 2020
Pembrolizumab
Pembrolizumab administered intravenously every 3 weeks.
Epacadostat
Epacadostat administered orally twice daily.
Placebo
Matching placebo administered orally twice daily.
Hopitaux Universitaires de Geneve HUG., Geneva
Rigshospitalet, Copenhagen
Inselspital Universitatsspital Bern, Bern
Austin Health-Austin Hospital, Heidelberg
Odense Universitetshospital, Odense
St John of God Murdoch Medical Clinic, Murdoch
Oncological Institute of Southern Switzerland, Bellinzona
Regionshospitalet Herning, Herning
Hospital del Mar, Barcelona
Universitaetsspital Zuerich, Zurich
Kantonsspital Winterthur, Winterthur
Seoul National University Bundang Hospital, Seongnam-si
Allegheny General Hospital, Pittsburgh
IRCCS A.O.U. San Martino - IST, Genova
Maryland Oncology Hematology, P.A., Rockville
Weinberg Cancer Institute at Franklin Square, Baltimore
Anne Arundel Health System Research Institute, Annapolis
Gacheon University Gil Medical Center, Incheon
PP PPC Acinus Medical and Diagnostic Centre, Kirovohrad
Hospital Tengku Ampuan Afzan, Kuantan
Hospital Clinico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Chungbuk National University Hospital, Cheongju-si
Southeastern Regional Medical Center, Inc., Newnan
Rambam Medical Center, Haifa
Florida Cancer Specialists (North Region), St. Petersburg
Florida Cancer Specialists (South Region), Fort Myers
Hospital Alvaro Cunqueiro, Vigo
Tennessee Oncology, PLLC/The Sarah Cannon Research Institute, Nashville
Tennessee Oncology, PLLC/The Sarah Cannon Research Institute, Chattanooga
Erciyes Universitesi Tip Fakultesi, Kayseri
Hospital Universitario Virgen Macarena, Seville
Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi, Konya
Volyn Regional Oncological Dispensary, Lutsk
Hospital Clinico de Valencia, Valencia
Dnipropetrovsk City Multidiscipline Clinical Hosp.4 of DRC, Dnipropetrovsk
MI Kryviy Rih Center of Dnipropetrovsk Regional Council, Kryvyi Rih
SA Tartu Ulikooli Kliinikum, Tartu
Chaim Sheba Medical Center, Ramat Gan
Minnesota Oncology Hematology, PA, Coon Rapids
University Malaya Medical Centre, Kuala Lumpur
Grigoriev Institute for medical Radiology NAMS of Ukraine, Kharkiv
Institut Kanser Negara - National Cancer Institute, Putrajaya
MI Odessa Regional Oncological Centre, Odesa
Nebraska Cancer Specialists, Omaha
Zaporizhzhya Regional Clinical Oncology Center, Zaporizhzhya
Texas Oncology-South Austin, Austin
Innovative Clinical Research Institute, Whittier
Pacific Cancer Medical Center, Inc., Anaheim
Central Clinical Hospital with polyclinic, Moscow
Moscow Research Oncology Institute named after P.A. Hertsen, Moscow
SBHI Leningrad Regional Clinical Hospital, Saint Petersburg
Belgorod Regional Oncology Dispensary, Belgorod
SBHI Samara Regional Clinical Oncology Dispensary, Samara
Republican Clinical Oncology Dispensary of Republic of Bashkortostan, Ufa
Meir Medical Center, Kfar Saba
Rabin Medical Center, Petah Tikva
Soroka Medical Center, Beersheba
UMass Memorial Medical Center, Worcester
Cross Cancer Institute, Edmonton
Moncton Hospital - Horizon Health Network, Moncton
William Osler Health System, Brampton
Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston
Sault Area Hospital, Sault Ste. Marie
Galway University Hospital, Galway
St Vincents University Hospital, Dublin
Policlinico Universitario Agostino Gemelli, Roma
National Hospital Organization Nagoya Medical Center, Nagoya
National Hospital Organization Shikoku Cancer Center, Matsuyama
Kurume University Hospital, Kurume
Kanazawa University Hospital, Kanazawa
Kanagawa Cancer Center, Yokohama
Sendai Kousei Hospital, Sendai
Kansai Medical University Hospital, Hirakata
Kindai University Hospital, Sayama
Shizuoka Cancer Center, Nagaizumi-chō
National Hospital Organization Kyushu Cancer Center, Fukuoka
Kyushu University Hospital, Fukuoka
Niigata Cancer Center Hospital, Niigata
Okayama University Hospital, Okayama
National Cancer Center Hospital, Tokyo
Nippon Medical School Hospital, Tokyo
The Cancer Institute Hospital of JFCR, Tokyo
Wakayama Medical University Hospital, Wakayama
Pantai Hospital Kuala Lumpur, Kuala Lumpur
Sarawak General Hospital, Kuching
Centrum Onkologii im. Prof. Franciszka Lukaszczyka, Bydgoszcz
Centrum Onkologii. Instytut im. Marii Sklodowskiej-Curie, Gliwice
Swietokrzyskie Centrum Onkologii SPZOZ, Kielce
Swietokrzyskie Centrum Onkologii SPZOZ, Kielce
Przychodnia Lekarska Komed, Konin
Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc, Olsztyn
Wojewodzki Szpital im. Zofii z Zamoyskich Tarnowskiej w Tarnobrzegu, Tarnobrzeg
Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw
Hospital General de Alicante, Alicante
Basken Uni. Adana Dr.Turgut Noyan Uygulama ve Arastirma Merkezi, Adana
Ankara University Medical Faculty, Ankara
Akdeniz Universitesi Tip Fakultesi, Antalya
Kyiv City Clinical Oncological Center, Kyiv
Dobryi Prognoz, Kyiv
Leeds Teaching Hospital NHS Trust. St. James University Hospital, Leeds
Lead Sponsor
Merck Sharp & Dohme LLC
INDUSTRY
Incyte Corporation
INDUSTRY